首页/数据集/Additional file 1 of Pegylated liposomal doxorubicin in patients with metastatic triple-negative breast cancer: 8-year experience of a single center

Additional file 1 of Pegylated liposomal doxorubicin in patients with metastatic triple-negative breast cancer: 8-year experience of a single center

NIAID Data Ecosystem2026-03-11 收录

三阴性乳腺癌治疗

脂质体阿霉素临床经验

数据链接：

https://figshare.com/articles/dataset/Additional_file_1_of_Pegylated_liposomal_doxorubicin_in_patients_with_metastatic_triple-negative_breast_cancer_8-year_experience_of_a_single_center/12198702 数据链接链接失效反馈

官方服务：

资源简介：

Additional file 1.

应用场景：

创建时间：

2020-04-27

三阴性乳腺癌治疗

激酶异构体选择性抑制剂

Off-target effects continue to impede disease interventions, particularly when targeting a specific protein within a family of similar proteins, such as kinase isoforms that play tumor-subtype-specifi

NIAID Data Ecosystem80

Table_1_Resveratrol Mediates the Apoptosis of Triple Negative Breast Cancer Cells by Reducing POLD1 Expression.xlsx

三阴性乳腺癌治疗

药物靶点发现

Resveratrol (RSV) is known to possess anticancer properties in many types of cancers like breast cancer, in which POLD1 may serve as a potential target. However, the anticancer mechanism of RSV on tri

NIAID Data Ecosystem70

A novel orally available seleno-purine molecule suppresses triple-negative breast cancer cell proliferation and progression to metastasis by inducing cytostatic autophagy

三阴性乳腺癌治疗

自噬调控

Patients with triple-negative breast cancer (TNBC) often have a poor prognosis largely due to lack of effective targeted therapy. Using a library of seleno-purines coupled to a high-throughput biochem

NIAID Data Ecosystem50

Au@109Pd core–shell nanoparticles conjugated to panitumumab for the combined β−—Auger electron therapy of triple-negative breast cancer

三阴性乳腺癌治疗

纳米放射治疗

Majkowska-Pilip, Agnieszka, 2025, "Au@109Pd core–shell nanoparticles conjugated to panitumumab for the combined β−—Auger electron therapy of triple-negative breast cancer", https://doi.org/10.18150/FJ

RepOD Repository for Open Data2025-09-04 更新80

Cytochalasin D as a potential MAPK family inhibitor for treating triple-negative breast cancer

三阴性乳腺癌治疗

MAPK信号通路

Cytochalasin D, a potent fungal metabolite, has garnered considerable attention due to its diverse biological activities and potential pharmacological applications. Renowned for its ability to disrupt

Taylor & Francis Group2025-02-27 更新50

Additional file 1 of Pegylated liposomal doxorubicin in patients with metastatic triple-negative breast cancer: 8-year experience of a single center

资源简介：

相关数据集